Evotec SE (EVO) Short-term Investments (2009 - 2026)
Evotec SE (EVO) reported Short-term Investments of $66558.1 for Q1 2026, down 26.48% on a YoY basis from $90531.5 in Q1 2025, and down 1.2% sequentially from $67366.7 in Q4 2025.
Evotec SE (EVO) Short-term Investments (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Short-term Investments data on file, last reported at $66558.1 in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 26.48% year-over-year to $66558.1; the trailing twelve-month figure through Mar 2026 stood at $66558.1 (down 26.48% YoY), and the FY2025 full-year result was $67366.7, down 98.53% from the prior year.
- Short-term Investments declined to $66558.1 in Q1 2026, from $67366.7 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $309.5 million in Q4 2022 to a low of $66558.1 in Q1 2026.
- A 5-year average of $32.0 million and a median of $90756.0 in 2025 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments jumped 1537512.05% in 2022 and sank 98.53% in 2025, its largest moves.
- Tracing EVO's Short-term Investments over 5 years: stood at $309.5 million in 2022, then sank by 67.6% to $100.3 million in 2023, then slumped by 95.43% to $4.6 million in 2024, then slumped by 98.53% to $67366.7 in 2025, then slipped by 1.2% to $66558.1 in 2026.
- Business Quant data shows EVO's Short-term Investments at $66558.1 in Q1 2026, $67366.7 in Q4 2025, and $73919.4 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66,558.06 |
| Dec 31, 2025 | 67,366.69 |
| Sep 30, 2025 | 73,919.35 |
| Jun 30, 2025 | 90,756.00 |
| Mar 31, 2025 | 90,531.49 |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 79,045.45 |
| Mar 31, 2024 | 88,680.80 |
| Dec 31, 2023 | 100.28 Mn |
| Dec 31, 2022 | 309.48 Mn |
| Sep 30, 2022 | 362,731.73 |
| Jun 30, 2022 | 203,687.25 |
| Mar 31, 2022 | 218,101.64 |
| Dec 31, 2021 | 302,008.33 |
| Sep 30, 2021 | 99,261.79 |
| Jun 30, 2021 | 13.25 |
| Dec 31, 2020 | 12.76 Mn |
| Sep 30, 2020 | 79.43 |
| Sep 30, 2010 | 62,483.39 |
| Jun 30, 2010 | 40,097.46 |